Continuing coverage: UTMB’s Elizabeth Jaramillo writes in this guest column that “by only testing men with certain risk factors [for prostate cancer], we can decrease the rate of overdiagnosis, false positives and unneeded biopsies with associated complications. This would better help doctors fulfill their oath to ‘do no harm.’”